At present, neither NICE nor the MHRA has issued guidance on the combined use of retatrutide and sermorelin, largely because retatrutide remains unlicensed in the UK
This article is not a substitute for professional medical advice, diagnosis or treatment, and should not be considered specific medical advice
SGLT2 inhibitors (such as dapagliflozin): Reduces cardiovascular risk
Schedule an Appointment Today References: Maimaituxun G, de Benedictis AD, Poston L, et al
Biomarker Context and Personalized GLP-1 Selection Before starting GLP-1 therapy, your provider typically reviews metabolic biomarkers: fasting glucose, HbA1c, lipid panel, liver function, and kidney metrics
The multifaceted role of GLP-1 in metabolic disorders, chronic inflammation, and aging